TY - JOUR
T1 - Leishmanicidal activity of betulin derivatives in leishmania amazonensis; effect on plasma and mitochondrial membrane potential, and macrophage nitric oxide and superoxide production
AU - Alcazar, Wilmer
AU - Alakurtti, Sami
AU - Padrón-Nieves, Maritza
AU - Tuononen, Maija Liisa
AU - Rodríguez, Noris
AU - Yli-Kauhaluoma, Jari
AU - Ponte-Sucre, Alicia
N1 - Funding Information:
Funding: This research was funded by the Universidad Central de Venezuela Council for Research, grants CDCH-UCV PI-09-8717-2013/1 (M.P.-N.) and PG-09-8646-2013/1 (A.P.-S.). This study also was supported by the Foundation for Research of Natural Resources in Finland, Marjatta ja Eino Kollin Säätiö, the Academy of Finland (Projects 252308, 264020, 265481) and the COST Action CM-0801 (New drugs for neglected diseases). Finally, A.P.-S. is grateful for the support conferred by the Alexander von Humboldt Foundation and the Siebold-Collegium Institute for Advanced Studies, University of Würzburg, Germany.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/2/4
Y1 - 2021/2/4
N2 - Herein, we evaluated in vitro the anti-leishmanial activity of betulin derivatives in Venezuelan isolates of Leishmania amazonensis, isolated from patients with therapeutic failure. Methods: We analyzed promastigote in vitro susceptibility as well as the cytotoxicity and selectivity of the evaluated compounds. Additionally, the activity of selected compounds was determined in intracellular amastigotes. Finally, to gain hints on their potential mechanism of action, the effect of the most promising compounds on plasma and mitochondrial membrane potential, and nitric oxide and superoxide production by infected macrophages was determined. Results: From the tested 28 compounds, those numbered 18 and 22 were chosen for additional studies. Both 18 and 22 were active (GI50 ≤ 2 µM, cytotoxic CC50 > 45 µM, SI > 20) for the reference strain LTB0016 and for patient isolates. The results suggest that 18 significantly depolarized the plasma membrane potential (p < 0.05) and the mitochondrial membrane potential (p < 0.05) when compared to untreated cells. Although neither 18 nor 22 induced nitric oxide production in infected macrophages, 18 induced superoxide production in infected macrophages. Conclusion: Our results suggest that due to their efficacy and selectivity against intracellular parasites and the potential mechanisms underlying their leishmanicidal effect, the compounds 18 and 22 could be used as tools for designing new chemotherapies against leishmaniasis.
AB - Herein, we evaluated in vitro the anti-leishmanial activity of betulin derivatives in Venezuelan isolates of Leishmania amazonensis, isolated from patients with therapeutic failure. Methods: We analyzed promastigote in vitro susceptibility as well as the cytotoxicity and selectivity of the evaluated compounds. Additionally, the activity of selected compounds was determined in intracellular amastigotes. Finally, to gain hints on their potential mechanism of action, the effect of the most promising compounds on plasma and mitochondrial membrane potential, and nitric oxide and superoxide production by infected macrophages was determined. Results: From the tested 28 compounds, those numbered 18 and 22 were chosen for additional studies. Both 18 and 22 were active (GI50 ≤ 2 µM, cytotoxic CC50 > 45 µM, SI > 20) for the reference strain LTB0016 and for patient isolates. The results suggest that 18 significantly depolarized the plasma membrane potential (p < 0.05) and the mitochondrial membrane potential (p < 0.05) when compared to untreated cells. Although neither 18 nor 22 induced nitric oxide production in infected macrophages, 18 induced superoxide production in infected macrophages. Conclusion: Our results suggest that due to their efficacy and selectivity against intracellular parasites and the potential mechanisms underlying their leishmanicidal effect, the compounds 18 and 22 could be used as tools for designing new chemotherapies against leishmaniasis.
KW - Betulin derivatives
KW - Drug resistance
KW - Leishmania
KW - Mitochondrial membrane potential
KW - Plasma membrane potential
KW - Therapeutic failure
UR - http://www.scopus.com/inward/record.url?scp=85100491627&partnerID=8YFLogxK
U2 - 10.3390/microorganisms9020320
DO - 10.3390/microorganisms9020320
M3 - Article
C2 - 33557150
AN - SCOPUS:85100491627
SN - 2076-2607
VL - 9
JO - Microorganisms
JF - Microorganisms
IS - 2
M1 - 320
ER -